CAITLIN JARDON: Open Payments
NPI 1356938138 · AMES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$973 in 35 payments from 10 companies in 2025. Trend: 2023 $156 · 2024 $1,209 · 2025 $973
Food & beverage: $973
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $395 |
| Lundbeck LLC | 3 | $185 |
| PFIZER INC. | 1 | $101 |
| Biogen, Inc. | 3 | $72 |
| Teva Pharmaceuticals USA, Inc. | 3 | $68 |
| LivaNova USA, Inc. | 2 | $48 |
| Genentech USA, Inc. | 1 | $39 |
| Lilly USA, LLC | 2 | $30 |
| SK Life Science, Inc. | 1 | $17 |
| ARGENX US, INC. | 1 | $17 |
Products named: QULIPTA, VYEPTI, NURTEC ODT, UBRELVY, VYALEV, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, AUSTEDO XR, VUMERITY.
Industry payments across IA — which companies pay providers there.
